Recent Changes

Login:

Login:
You can login using:
user@refbase.net / user
admin@refbase.net / admin
guest@refbase.net / guest
 
  Most recently added publications:  
 
Fabiani, E., Fianchi, L., Falconi, G., Boncompagni, R., Criscuolo, M., Guidi, F., et al. (2014). The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes. Leuk Lymphoma, 55(7), 1538–1543.
toggle visibility
Valencia, A., Masala, E., Rossi, A., Martino, A., Sanna, A., Buchi, F., et al. (2014). Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine. Leukemia, 28(3), 621–628.
toggle visibility
Ottone, T., Hasan, S. K., Voso, M. T., Ledda, A., Montefusco, E., Fenu, S., et al. (2014). Genomic analysis of therapy-related acute promyelocytic leukemias arising after malignant and non-malignant disorders. Am J Hematol, 89(3), 346–347.
toggle visibility
Breccia, M., Voso, M. T., Maurillo, L., Niscola, P., Fianchi, L., Aloe Spiriti, M. A., et al. (2014). Real-life experience with azacitidine in myelodysplastic syndromes according to IPSS cytogenetic profile (Vol. 89).
toggle visibility
Efficace, F., Gaidano, G., Sprangers, M., Cottone, F., Breccia, M., Voso, M. T., et al. (2014). Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes. Ann Oncol, 25(2), 447–454.
toggle visibility

About

  This literature database is maintained by the Web Reference Database (refbase). You're welcome to send any questions or suggestions to our feedback address. The database is powered by refbase, an open source database front-end for managing scientific literature & citations. powered by refbase